|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
+4.17% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | 1.97x | 20.32x | 43.14x | 62.34M | |
| -.--% | -.--% | 17.96x | 1.56x | 0.74x | 11.7x | 12.56x | 15.39B | |
| -.--% | 0.95% | 21.69x | 2.64x | 1.08x | 16.72x | 17.09x | 7.24B | |
| 2.08% | 2.43% | 16.38x | 1.71x | 0.71x | 7.41x | 9.32x | 5.73B | |
| 3.13% | 3.46% | 13.72x | 2.07x | 0.88x | 6.34x | 8.3x | 3.9B | |
| 3.98% | 4.39% | 16.2x | 7.33x | 0.99x | 7.36x | 10.23x | 3.38B | |
| 5.67% | 6.29% | 14.59x | 4.37x | 1.23x | 7.51x | 14.56x | 3.26B | |
| 5.13% | 5.43% | 13.18x | 2.47x | 0.54x | 4.27x | 7.04x | 2.89B | |
| 1.71% | 2.14% | 24.02x | 4.06x | 0.68x | 8.81x | 14.39x | 1.76B | |
| 0.08% | -.--% | -49.19x | 2.17x | 0.36x | 14.5x | 205.73x | 1.14B | |
| 5.64% | 6.34% | 11.74x | 2.36x | 0.86x | 7.05x | 13.3x | 980M | |
| 4.24% | 4.78% | 11.96x | 0.85x | 0.28x | 2.74x | 5.65x | 948M | |
| 1.33% | 1.93% | 27.09x | 7.31x | 0.98x | 13.37x | 21.14x | 831M | |
| 0.4% | 0.41% | 13.06x | 1.83x | 0.64x | 7.85x | 12.73x | 648M | |
| Average | 2.57% | 2.97% | 11.72x | 3.13x | 0.85x | 9.71x | 28.23x | 3.44B | |
| Weighted average by Cap. | 1.77% | 2.12% | 15.83x | 2.65x | 0.83x | 10.15x | 16.85x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
